BioMarin Pharmaceuticals BMRN Intangible assets — net
Intangible assets — net at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's intangible assets — net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's intangible assets — net?
- BioMarin Pharmaceuticals (BMRN) reported intangible assets — net of $204.66M in Q1 2026.
- How has BioMarin Pharmaceuticals's intangible assets — net changed year-over-year?
- BioMarin Pharmaceuticals's intangible assets — net decreased by 17.3% year-over-year, from $247.35M to $204.66M.
- What is the long-term trend for BioMarin Pharmaceuticals's intangible assets — net?
- Over 3 years (2022 to 2025), BioMarin Pharmaceuticals's intangible assets — net has grown at a -14.2% compound annual growth rate (CAGR), from $338.57M to $213.84M.